Literature DB >> 26873399

Genetic Factors That Affect Risk of Alcoholic and Nonalcoholic Fatty Liver Disease.

Quentin M Anstee1, Devanshi Seth2, Christopher P Day3.   

Abstract

Genome-wide association studies and candidate gene studies have informed our understanding of factors contributing to the well-recognized interindividual variation in the progression and outcomes of alcoholic liver disease and nonalcoholic fatty liver disease. We discuss the mounting evidence for shared modifiers and common pathophysiological processes that contribute to development of both diseases. We discuss the functions of proteins encoded by risk variants of genes including patatin-like phospholipase domain-containing 3 and transmembrane 6 superfamily member 2, as well as epigenetic factors that contribute to the pathogenesis of alcoholic liver disease and nonalcoholic fatty liver disease. We also discuss important areas of future genetic research and their potential to affect clinical management of patients.
Copyright © 2016 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ALD; Cirrhosis; Gene; NAFLD; PNPLA3; TM6SF2

Mesh:

Year:  2016        PMID: 26873399     DOI: 10.1053/j.gastro.2016.01.037

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  66 in total

1.  Independent and additive effects of PNPLA3 and TM6SF2 polymorphisms on the development of non-B, non-C hepatocellular carcinoma.

Authors:  Maneerat Raksayot; Natthaya Chuaypen; Apichaya Khlaiphuengsin; Nutcha Pinjaroen; Sombat Treeprasertsuk; Yong Poovorawan; Yasuhito Tanaka; Pisit Tangkijvanich
Journal:  J Gastroenterol       Date:  2018-11-30       Impact factor: 7.527

2.  Current Management and Future Treatment of Alcoholic Hepatitis.

Authors:  Mack C Mitchell; Thomas Kerr; H Franklin Herlong
Journal:  Gastroenterol Hepatol (N Y)       Date:  2020-04

Review 3.  Alcohol-Associated Liver Disease: East Versus West.

Authors:  Phunchai Charatcharoenwitthaya; Suthat Liangpunsakul; Teerha Piratvisuth
Journal:  Clin Liver Dis (Hoboken)       Date:  2021-01-13

4.  Baseline Parameters in Clinical Trials for Nonalcoholic Steatohepatitis: Recommendations From the Liver Forum.

Authors:  Yuval A Patel; Joanne C Imperial; Andrew J Muir; Quentin M Anstee; David DeBrota; Lara Dimick-Santos; Claudia Filozof; Ruby Mehta; Arun J Sanyal; Elmer Schabel; Brent A Neuschwander-Tetri; Veronica Miller
Journal:  Gastroenterology       Date:  2017-07-27       Impact factor: 22.682

5.  Binge drinking as a risk factor for advanced alcoholic liver disease.

Authors:  Meritxell Ventura-Cots; Ariel E Watts; Ramon Bataller
Journal:  Liver Int       Date:  2017-09       Impact factor: 5.828

6.  Genetic Determinants of Circulating Lipoproteins in Nonalcoholic Fatty Liver Disease.

Authors:  Zhenghui G Jiang; Elliot B Tapper; Misung Kim; Margery A Connelly; Sarah A Krawczyk; Eric U Yee; Mark A Herman; Kenneth J Mukamal; Michelle Lai
Journal:  J Clin Gastroenterol       Date:  2018 May/Jun       Impact factor: 3.062

Review 7.  New insights into genetic predisposition and novel therapeutic targets for nonalcoholic fatty liver disease.

Authors:  Mary Barbara; Andrea Scott; Naim Alkhouri
Journal:  Hepatobiliary Surg Nutr       Date:  2018-10       Impact factor: 7.293

8.  Commonalities and Distinctions Between Alcoholic and Nonalcoholic Fatty Liver Disease.

Authors:  Arun J Sanyal; Philippe Mathurin; Laura A Nagy
Journal:  Gastroenterology       Date:  2016-05-04       Impact factor: 22.682

9.  Diagnostic modalities for nonalcoholic fatty liver disease, nonalcoholic steatohepatitis, and associated fibrosis.

Authors:  Zobair M Younossi; Rohit Loomba; Quentin M Anstee; Mary E Rinella; Elisabetta Bugianesi; Giulio Marchesini; Brent A Neuschwander-Tetri; Lawrence Serfaty; Francesco Negro; Stephen H Caldwell; Vlad Ratziu; Kathleen E Corey; Scott L Friedman; Manal F Abdelmalek; Stephen A Harrison; Arun J Sanyal; Joel E Lavine; Philippe Mathurin; Michael R Charlton; Zachary D Goodman; Naga P Chalasani; Kris V Kowdley; Jacob George; Keith Lindor
Journal:  Hepatology       Date:  2018-07       Impact factor: 17.425

10.  Nuclear lamina genetic variants, including a truncated LAP2, in twins and siblings with nonalcoholic fatty liver disease.

Authors:  Graham F Brady; Raymond Kwan; Peter J Ulintz; Phirum Nguyen; Shirin Bassirian; Venkatesha Basrur; Alexey I Nesvizhskii; Rohit Loomba; M Bishr Omary
Journal:  Hepatology       Date:  2018-03-24       Impact factor: 17.425

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.